Skip to main content

Anal Carcinoma Surveillance Counterpoint: Australia

  • Chapter
  • First Online:
Patient Surveillance After Cancer Treatment

Abstract

Surveillance after treatment of anal carcinoma is not as firmly established as surveillance for colorectal cancer. The rarity of the disease means that there is a paucity of data or clinical trials comparing different regimens. The current standard of care for squamous cell carcinoma of the anus consists of combined modality treatment, with a surveillance regimen that aims at detecting recurrent or persistent disease, assessing treatment tolerance and related complications, with salvage surgery being reserved for locoregional failures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. www.aihw.gov.au

  2. Prestage G, Ferris J, Grierson J, et al. Homosexual men in Australia: population, distribution and HTV prevalence. Sex Health. 2008;5:97–102.

    Article  PubMed  Google Scholar 

  3. National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the prevention, early detection and management of colorectal cancer. The Cancer Council Australia, Australian Cancer Network, The Commonwealth of Australia, Canberra; 2005.

    Google Scholar 

  4. Fleshner P, Chalasani S, Chang G, et al. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2008;51:2–9.

    Article  PubMed  Google Scholar 

  5. Young SC, Solomon MJ, Hruby G, Frizelle FA. Review of 120 anal cancer patients. Colorectal Dis. 2009;11:909–14. Epub 2008 Oct 25.

    Article  PubMed  CAS  Google Scholar 

  6. Christensen A, Nielsen M, Svendsen L, Engelholm S. Three-dimensional anal endosonography may improve detection of recurrent anal cancer. Dis Colon Rectum. 2006;49:1527–32.

    Article  PubMed  Google Scholar 

  7. Goldman S, Svensson C, Bronnergard M, Glimelius B, Wallin G. Prognostic significance of serum concentration of squamous cell carcinoma antigen in anal epidermal carcinoma. Ing J Colorectal Dis. 1993;8:98–102.

    Article  CAS  Google Scholar 

  8. Petrelli NJ, Palmer M, Herrera L, Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer. 1992;70:35–9.

    Article  PubMed  CAS  Google Scholar 

  9. Tasevski R, De Winton E, Ngan S, Mackay J, Hicks R, Heriot A. CR13 utility of 18- fluorodeoxyglucose PET in the staging and management of anal cancer. ANZ J Surg. 2007;77(Suppl sl):A17.

    Article  Google Scholar 

  10. Roohipour R, Patil S, Goodman K, et al. Squamous-cell carcinoma of the anal canal:·predictors of treatment outcome. Dis Colon Rectum. 2008;51:147–53.

    Article  PubMed  Google Scholar 

  11. Gervaz P, Hirschel B, Morel P. Molecular biology of squamous cell carcinoma of the anus. Br J Surg. 2006;93:531–8.

    Article  PubMed  CAS  Google Scholar 

  12. Place R, Gregorcyk S, Huber P, Simmang C. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum. 2001;44:506–12.

    Article  PubMed  CAS  Google Scholar 

  13. Martin F, Bower M. Anal intraepithelial neoplasia in HIV positive people. Sex Transm Infect. 2001;5:327–31.

    Article  Google Scholar 

  14. Hoffinan R, Welton M, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999;44:127–31.

    Article  Google Scholar 

  15. Ajani J, Winter K, Gunderson L, et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal. JAMA. 2008;299:1914–21.

    Article  PubMed  CAS  Google Scholar 

  16. Renehan A, Saunders M, Schofield P, O’Dwyer S. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg. 2005;92:605–14.

    Article  PubMed  CAS  Google Scholar 

  17. Mariani P, Ghanneme A, De la Rochefordiere A, Girodet J, Falcou M, Salmon R. Abdominoperineal resection for anal cancer. Dis Colon Rectum. 2008;51:1495–501.

    Article  PubMed  CAS  Google Scholar 

  18. Nilsson PJ, Svenson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg. 2002;89:1425–9.

    Article  PubMed  CAS  Google Scholar 

  19. Ferenschild F, Vermaas M, Hofer SO, Verhoef C, Eggermont A, de Witt JHW. Salvage abdominoperineal resection and perineal wound healing in local recurrent or persistent anal cancer. World J Surg. 2005;29:1452–7.

    Article  PubMed  Google Scholar 

  20. Sunesen KG, Buntzen T, Lindegaard J, Norgaard M, Laurberg S. Perineal healing and survival after anal cancer salvage surgery: 10-year experience with primary perineal reconstruction using the vertical rectus abdominis myocutaneous flap. Ann Surg Oncol. 2009;16:68–77. Epub 2008 Nov 5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Toufic El-Khoury M.B.B.S., F.R.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Humana Press

About this chapter

Cite this chapter

El-Khoury, T., Solomon, M., Young, J. (2013). Anal Carcinoma Surveillance Counterpoint: Australia. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_39

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-969-7_39

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-968-0

  • Online ISBN: 978-1-60327-969-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics